SAN FRANCISCO (AP) - One of the companies alleged to have conspired to keep generic versions of a popular opioid treatment off the market says the antitrust lawsuit has no merit.
Attorneys general for 35 states filed a complaint in the U.S. District Court for the Eastern District of Pennsylvania on Thursday, alleging that British drugmaker Indivior and New Jersey's MonoSol Rx conspired to corner the market on Suboxone.
Oral drug delivery company says opioid lawsuit has no merit
Aucun commentaire:
Enregistrer un commentaire